Literature DB >> 15855009

Self HSP60 peptide serves as an immunogenic carrier for a CTL epitope against persistence of murine cytomegalovirus in the salivary gland.

Ory Rouvio1, Tatyana Dvorkin, Hila Amir-Kroll, Danit Atias, Irun R Cohen, Bracha Rager-Zisman, Angel Porgador.   

Abstract

Murine cytomegalovirus (MCMV) infection is associated with persistence of virus in the salivary glands, despite relatively rapid clearance of virus from the spleen. An effective immunization against MCMV should prevent such viral persistence. We previously reported that a peptide (p458) from the sequence of the 60 kDa heat shock protein (HSP60) molecule in a conjugate vaccine can provide T cell help for the induction of protecting antibody against bacterial capsular polysaccharides. We now report that the p458 peptide as a carrier peptide can also enhance the immunogenicity of a dominant CTL epitope of the MCMV pp89 antigen-89pep. We synthesized a linear combined peptide: chimeric p458-89pep. We immunized young BALB/c mice and challenged them with MCMV. We found that the p458-89pep chimeric peptide was more effective than the 89pep in inducing 89pep-specific IFN(gamma) secretion and specific CTL activity. Moreover, the p458-89pep chimeric peptide induced sustained IFN(gamma) secretion in the salivary gland specific to 89pep and only this immunization was associated with clearance of virus from the salivary gland. These results suggest that a peptide epitope of HSP60 may be advantageous as a T cell carrier peptide in the induction of specific T cell immunity against infectious agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855009     DOI: 10.1016/j.vaccine.2005.02.002

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.

Authors:  Orly Gershoni-Yahalom; Shimon Landes; Smadar Kleiman-Shoval; David Ben-Nathan; Michal Kam; Bat-El Lachmi; Yevgeny Khinich; Michael Simanov; Itzhak Samina; Anat Eitan; Irun R Cohen; Bracha Rager-Zisman; Angel Porgador
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

2.  Hsp65-Producing Lactococcocus lactis Prevents Antigen-Induced Arthritis in Mice.

Authors:  Guilherme Gusmao-Silva; Sarah Leão Fiorini Aguiar; Mariana Camila Gonçalves Miranda; Mauro Andrade Guimarães; Juliana Lima Alves; Angélica Thomaz Vieira; Denise Carmona Cara; Anderson Miyoshi; Vasco Ariston Azevedo; Rafael Pires Oliveira; Ana Maria Caetano Faria
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

3.  Innate immunity defines the capacity of antiviral T cells to limit persistent infection.

Authors:  Daniel M Andrews; Marie J Estcourt; Christopher E Andoniou; Matthew E Wikstrom; Andrea Khong; Valentina Voigt; Peter Fleming; Hyacinth Tabarias; Geoffrey R Hill; Robbert G van der Most; Anthony A Scalzo; Mark J Smyth; Mariapia A Degli-Esposti
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

Review 4.  Leptin-based adjuvants: an innovative approach to improve vaccine response.

Authors:  Sarah J White; Matthew J Taylor; Ryan T Hurt; Michael D Jensen; Gregory A Poland
Journal:  Vaccine       Date:  2013-01-29       Impact factor: 3.641

Review 5.  Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease.

Authors:  E Zonneveld-Huijssoon; S Albani; B J Prakken; F van Wijk
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

Review 6.  Vaccines for TB: Lessons from the Past Translating into Future Potentials.

Authors:  Gee Jun Tye; Min Han Lew; Yee Siew Choong; Theam Soon Lim; Maria Elena Sarmiento; Armando Acosta; Mohd Nor Norazmi
Journal:  J Immunol Res       Date:  2015-06-03       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.